• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【药物名称】AR-C102222

【化学名称】5-(4'-Amino-5',8'-difluoro-1',2'-dihydrospiro[piperidine-4,2'-quinazoline]-1-ylcarbonyl)pyridine-2-carbonitrile

【CA登记号】253771-21-0, 190010-48-1 (diHCl)

【 分 子 式 】C19H16F2N6O

【 分 子 量 】382.37577

【开发单位】AstraZeneca Charnwood (Originator)

【药理作用】Antiarthritic Drugs, TREATMENT OF MUSCULOSKELETAL & CONNECTIVE TISSUE DISEASES, Inducible Nitric Oxide Synthase (NOS-2) Inhibitors

合成路线1

Displacement of the 2-fluoro group in 2,3,6-trifluorobenzonitrile (I) with aqueous ammonia leads to 2-amino-3,6-difluorobenzonitrile (II). Addition of hydroxylamine to the nitrile (II) in the presence of NaOMe affords benzamidoxime (III). Subsequent catalytic hydrogenation of (III) over Raney nickel furnishes benzamidine (IV).

1 Tinker, A.C.; Beaton, H.G.; Boughton-Smith, N.; Cook, T.R.; Cooper, S.L.; Fraser-Rae, L.; Hallam, K.; Hamley, P.; McInally, T.; Nicholls, D.J.; Pimm, A.D.; Wallace, A.V.; 1,2-Dihydro-4-quinazolinamines: Potent, highly selective inhibitors of inducible nitric oxide synthase which show antiinflammatory activity in vivo. J Med Chem 2003, 46, 6, 913.
2 Hamley, P.R.J.; Pimm, A.D.; Tinker, A.C.; Beaton, H.G.; McInally, T. (AstraZeneca plc); Pharmaceutically active quinazoline cpds.. EP 0858451; JP 1999513679; WO 9714686 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 63408 2,3,6-trifluorobenzonitrile 136514-17-5 C7H2F3N 详情 详情
(II) 63409 2-amino-3,6-difluorobenzonitrile 190011-81-5 C7H4F2N2 详情 详情
(III) 63410 2-amino-3,6-difluoro-N'-hydroxybenzenecarboximidamide C7H7F2N3O 详情 详情
(IV) 63411 2-amino-3,6-difluorobenzenecarboximidamide C7H7F2N3 详情 详情

合成路线2

4-Piperidone ethylene ketal (V) is acylated with 6-bromonicotinic acid (VI) employing 1,1'-carbonyldiimidazole to yield amide (VII). The bromide group of (VII) is then displaced with CuCN in hot DMF producing nitrile (VIII). Finally, condensation between N-acylpiperidone (VIII) and amidine (IV) in refluxing EtOH leads to the target spiro quinazoline.

1 Tinker, A.C.; Beaton, H.G.; Boughton-Smith, N.; Cook, T.R.; Cooper, S.L.; Fraser-Rae, L.; Hallam, K.; Hamley, P.; McInally, T.; Nicholls, D.J.; Pimm, A.D.; Wallace, A.V.; 1,2-Dihydro-4-quinazolinamines: Potent, highly selective inhibitors of inducible nitric oxide synthase which show antiinflammatory activity in vivo. J Med Chem 2003, 46, 6, 913.
2 Hamley, P.R.J.; Pimm, A.D.; Tinker, A.C.; Beaton, H.G.; McInally, T. (AstraZeneca plc); Pharmaceutically active quinazoline cpds.. EP 0858451; JP 1999513679; WO 9714686 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(IV) 63411 2-amino-3,6-difluorobenzenecarboximidamide C7H7F2N3 详情 详情
(V) 11338 1,4-Dioxa-8-azaspiro[4.5]decane; 4-Piperidone ethylene ketal 177-11-7 C7H13NO2 详情 详情
(VI) 63412 6-bromonicotinic acid C6H4BrNO2 详情 详情
(VII) 63413 (6-bromo-3-pyridinyl)(1,4-dioxa-8-azaspiro[4.5]dec-8-yl)methanone C13H15BrN2O3 详情 详情
(VIII) 63414 5-(1,4-dioxa-8-azaspiro[4.5]dec-8-ylcarbonyl)-2-pyridinecarbonitrile C14H15N3O3 详情 详情
Extended Information